AtriCure (ATRC) Operating Expenses (2010 - 2026)

AtriCure (ATRC) has 17 years of Operating Expenses data on file, last reported at $108.8 million in Q1 2026.

• Operating Expenses for Q1 2026 came in at $108.8 million, up 10.35% year-over-year; the trailing twelve-month figure through Mar 2026 was $420.4 million (up 6.73% YoY), and the FY2025 annual result was $410.2 million, up 5.85% from the prior year.
• Operating Expenses improved to $108.8 million in Q1 2026 per ATRC's latest filing, from $102.8 million in the prior quarter.
• Over five years, Operating Expenses peaked at $108.8 million in Q1 2026 and troughed at $69.2 million in Q4 2022.
• A 5-year average of $89.5 million and a median of $92.2 million in 2024 frame the typical range for Operating Expenses.
• The sharpest annual moves came in 2022 and 2025: Operating Expenses jumped 255.97% in 2022, then dropped 4.01% in 2025.
• A 5-year view of Operating Expenses shows it stood at $69.2 million in 2022, then increased by 27.78% to $88.5 million in 2023, then increased by 21.09% to $107.1 million in 2024, then dropped by 4.01% to $102.8 million in 2025, then increased by 5.77% to $108.8 million in 2026.
• Business Quant data shows ATRC's Operating Expenses at $108.8 million in Q1 2026, $102.8 million in Q4 2025, and $101.1 million in Q3 2025.